Tuesday, May 22, 2012

 
 
 
 
 
Put this Big Pharma stock on your radar
Advertisement
Monday, November 30, 2009
Text Size: increase text size decrease text size

From 24/7 Wall Street:

Merck & Co., Inc. (NYSE: MRK) barely has its Schering-Plough deal behind it. And today came the announcement of its dividend rate, but more importantly came word of a large share repurchase program.

The quarterly dividend for common stock is remaining at $0.38 per quarter, which gives a yield of almost 4.20%. It also declared a quarterly dividend of $3.75 per share on the company’s mandatoryconvertible preferred stock for the first quarter of 2010.

But this buyback is what will excite most investors...

Read full article...

More on stocks:

Jeff Clark: There are 2 kinds of bulls right now

What the world's best investors are buying right now

Richard Russell: "The final bear market bottom lies ahead"


Topics: Stocks | Dividends
RSS Feed

 
©2012 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202.